How Family Offices Should Approach Investment in the Life Sciences and Healthcare Industry

Posted June 14, 2018 by OCP | Post a Comment

The fundraising landscape for healthcare and life science companies has changed dramatically over the past several years. Entrepreneurs and business owners in these industries need to look toward emerging categories of investors to provide the funding that was historically serviced by venture capital firms (VC’s). Corporate venture funds, angels and angel networks, government agencies, and foundations are all actively investing in these sectors and represent newer, non-traditional avenues for raising capital. However, the latest growing trend is the participation of family offices.

(more…)

Family Office, Healthcare, Life Sciences, Mergers & Aquisitions, Investment banking, M&A Articles

Objective Capital Partners Trever Acers Honored in 2018 San Diego’s 500 Influential Business Leader List

Posted December 18, 2017 by David Crean | Post a Comment

San Diego, CA- December 18, 2017 – Objective Capital Partners, a middle-market M&A Advisory Firm located in Southern California, is pleased to announce that Trever Acers, a Managing Director at the firm, has been recognized by the San Diego Business Journal in the 2018 edition of the San Diego 500, The Book of Influential Business Leaders. The publication’s editorial team selected the honorees from every sector of the San Diego Business community.

(more…)

Influential 500, News Announcement, Trever Acers, objective capital partners, SDBJ, Investment banking, San Diego Business Journal

Bio Buck$ Fast Forward: A Start-up’s Guide to Investment Banks

Posted November 05, 2017 by David Crean | Post a Comment

Objective Capital’s David H. Crean to Serve as Guest Panelist at LaunchBio Event, November 14, 2017

San Diego, November 9, 2017 — Objective Capital Partners, a middle market M&A Advisory Firm located in Southern California, is pleased to announce that David H. Crean, Ph.D., one of its Managing Directors who heads its thriving life science and healthcare practice, has been invited to speak as a guest panelist at LaunchBio Series Event for life science companies entitled BIO Buck$ Fast Forward: A Start-ups Guide to Investment Banks. Dr. Crean will be joined by Charlie Adams, Cantor Fitzgerald and Tony Grover, VP of Business Development at Banyan Biomarker.

(more…)

Capital Financing, m&A, BioBucks, David H. Crean, Entrepreneurs, LaunchBio, Partnering, Start-ups, Investment banking, life science, Uncategorized

M&A Deal Represented by Objective Capital Partners Selected as Finalist by The M&A Advisor

Posted October 09, 2017 by David Crean | Post a Comment

Information Technology Deal of the Year Finalist

New York, NY and San Diego, CA- October 11, 2017 –  The M&A Advisor is pleased to announce that one of the deals represented by Objective Capital Partners, a middle-market investment banking firm located in Southern California, was selected as a Finalist in the category for Information Technology Deal of The Year for the 16th Annual M&A Advisor Awards.  Objective Capital Partners served as the exclusive financial advisor to an undisclosed digital healthcare company on its confidential sale to a large private equity-backed acquirer.  Two other advisers on the deal included Kirkland & Ellis LLP and Sheppard Mullin Richter & Hampton LLP.  This is the third time in as many years that a deal represented by the investment banking firm was selected as a Finalist by the M&A Advisor.

(more…)

Information Technology Deal, Finalist Awards, mergers and acquisitions, objective capital partners, Private Equity-Backed Acquirer, Sale of a Private Company, Investment banking, The M&A Advisor, Uncategorized

Objective Capital’s Dr. David Crean to Address International Bar Association’s 5th Annual World Life Sciences Conference in San Diego, CA

Posted May 30, 2017 by David Crean | Post a Comment

Panel Discussion on Life Sciences Transactions, Research Collaborations, and Licensing Models to be presented on June 17, 2017

San Diego, CA- May 31, 2017 - Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, is pleased to announce that one of its Managing Directors, David H. Crean, Ph.D., will serve as a panel member and address legal professionals at the 5th Annual World Life Sciences Conference, June 16–17, 2017 at the Westin San Diego Gaslamp Quarter, San Diego, CA. The conference is presented by the International Bar Association (IBA), a global voice for the legal profession. The event will feature dynamic roundtable sessions covering the hottest topics and the latest developments from across the different sectors of the Life Science Industry.

(more…)

Healthcare & Life Sciences, International Bar Association, Licensing, Collaborations, David H. Crean, IBA, Life Sciences, objective capital partners, Partnerships, Investment banking, Uncategorized

Objective Capital Partners Announced as Finalist for Boutique Investment Banking Firm of the Year

Posted May 08, 2017 by David Crean | Post a Comment

San Diego, CA, May 9, 2017 Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, has been announced as a finalist for Boutique Investment Banking Firm of the Year as part of the 9th Annual International M&A Advisor Awards. The M&A Advisor also recognized Objective Capital Partners as finalists in categories for Consumer Discretionary Deal of the Year and Corporate Strategic Deal of the Year ($100mm-250mm).  This is the third year in a row that Objective Capital Partners has been nominated by The M&A Advisor as an award finalist.

(more…)

investment bank, m&A, mergers & Acquisitions, objective capital partners, Advisor of the Year, Investment banking, M&A Articles

A Roundtable for Life Science Executives: Private Capital Raising

Posted April 17, 2017 by David Crean | Post a Comment

Join CohnReznick, Objective Capital Partners, Wilson Sonsini and an Exclusive Group of Life Science Executives for Engaging Discussion on May 17

San Diego, CA- April 18, 2017 - Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, is pleased to announce that they have teamed up with CohnReznick and Wilson Sonsini Goodrich & Rosati  to sponsor a  Roundtable discussion on Private Capital Raising for Life Science Companies on Wednesday, May 17, 2017.  The Roundtable discussion will take place from 7:30-9:00 am at Barney & Barney in San Diego, CA. 

(more…)

Capital Raising, m&A, mergers & Acquisitions, Wilson Sonsini, Avalon Ventures, Barney & Barney, David H. Crean, Life Sciences, Marty Waters, objective capital partners, CohnReznick, Investment banking, Jay Lichter, Uncategorized

Objective Capital Opens Los Angeles Office

Posted March 07, 2017 by admin | Post a Comment

San Diego, CA- March 7, 2017 - Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, is pleased to announce that the firm has opened a Los Angeles office as part of Objective Capital’s continued commitment to serve its Los Angeles and Orange County clients. This new office will broaden Objective Capital’s footprint in the Southern California region and further support Objective Capital’s team members serving its Los Angeles and Orange County clients as the firm continues to grow. Channing Hamlet, Managing Director of Objective Capital, will serve as principal lead at the Los Angeles office.

(more…)

business valuation, Capital Raising, m&A, mergers & Acquisitions, Orange County, Trever Acers, Channing Hamlet, David H. Crean, Middle Market, objective capital partners, Southern California, Investment banking, Los Angeles, San Diego, Uncategorized

Objective Capital Partners Strengthens Its Healthcare & Life Sciences Investment Banking Practice with the Addition of Jack J. Florio

Posted January 18, 2017 by admin | Post a Comment

San Diego, CA- January 18, 2017 - Objective Capital Partners, a leading M&A investment banking firm focused on transactions for companies with enterprise values up to $500 million, is pleased to welcome the addition of Jack J. Florio fueling its ability to secure and execute high quality deals in the healthcare & life sciences space.  Mr. Florio brings more 40 years’ of global life sciences experience in major pharmaceutical, biotechnology, medical devices and digital health companies.  He has held senior management roles in both small and large companies including CEO, Corporate Development and Business Development.  He will serve as Managing Director and help with execution of the firm’s investment banking activities in the healthcare & life science space alongside David H. Crean, Ph.D..

(more…)

Healthcare & Life Sciences, Jack Florio, objective capital partners, Investment banking, Uncategorized

Objective Capital Wins Four Awards At 2016 Advisor of the Year

Posted October 31, 2016 by admin | Post a Comment

San Diego, CA- November 1, 2016 - Objective Capital Partners, a leading M&A investment banking firm focused on transactions for companies with enterprise values up to $500MM, is pleased to announce that Trever Acers, Channing Hamlet and Michael Kim were the recipients of awards at 2016 Advisor of the Year. The awards acknowledged local middle market mergers and acquisitions professionals who have significantly contributed to the successful sale, expansion or recapitalization of their clients’ companies.

(more…)

investment bank, m&A, mergers & Acquisitions, Boutique Investment Bank, objective capital partners, Advisor of the Year, Award winners, Investment banking, Uncategorized

This article is provided for informational purposes only and does not constitute an offer, invitation or recommendation to buy, sell, subscribe for or issue any securities. While the information provided herein is believed to be accurate and reliable, Objective Capital Partners and BA Securities, LLC makes no representations or warranties, expressed or implied, as to the accuracy or completeness of such information. It should not be construed as investment, legal, or tax advice and may not be reproduced or distributed to any person.

Our Services

Learn about our services and how we can help you sell your business successfully.

LEARN MORE

Contact Us

San Diego Office:
3636 Nobel Dr., Suite 160
San Diego, CA 92122

Los Angeles Office:
10100 Santa Monica Blvd., Suite 300
Los Angeles, CA 90067

Trever Acers
Managing Director
858.663.8662 telephone
trever.acers@objectivecp.com

Channing Hamlet
Managing Director
858.342.4939 telephone
channing.hamlet@objectivecp.com

David H. Crean, Ph.D.
Managing Director
858.461.9490 telephone
david.crean@objectivecp.com

Jack J. Florio
Managing Director
858.864.4339 telephone
jack.florio@objectivecp.com